MUHC research news
COX-2 inhibitor increases risk of heart attack in low-risk seniors
New research published in the online version of the Annals of Internal Medicine today documents an increased risk of heart attack with one of the COX-2 inhibitors used in elderly adults with no previous history of heart attack.
Combined radiation and chemotherapy increases breast cancer survival
For patients with high-risk breast cancer treated with radical mastectomy and adjuvant chemotherapy, the addition of radiation therapy leads to better survival outcomes with few long-term toxic effects.
Québec Science magazine recognizes two MUHC scientists
The discoveries of two investigators from the Research Institute of the McGill University Health Centre (MUHC) have been listed in the prestigious Québec Science magazine's Top Ten Discoveries of 2004.
McGill researchers to test new leukemia drug
Chronic myeloid leukemia (CML) is a malignant cancer of the blood that affects people of all ages.
MUHC launches Canada's first medical cannabis study
A first-of-its-kind study of safety issues surrounding the medical use of cannabis has just been launched.
New study examines cancer care and mortality rate
A first-ever study of how evolving diagnostic and therapy guidelines in conjunction with community programs affect breast cancer population mortality found a possible link between death rates and the way cancer care is organized.
Medical genetics research group receives funding boost
Funding for the CIHR Group in Medical Genetics was recently renewed for another five years, starting today.
MUHC researchers link rare form of anemia to epoetin use
Independent research teams based at Northwestern University in the U.S. and at the McGill University Health Centre (MUHC) in Canada are reporting similar findings about a rare and potentially life-threatening form of anemia known as antibody-associated pure red-cell aplasia (PRCA).
New gene identified in breast cancer
Researchers at the Research Institute of the McGill University Health Centre and McMaster University have identified a new player in breast cancer.
New HIV findings
Researchers show HIV patients may be infected with more than one type of HIV: HIV superinfection.
New MUHC research study looks at quality of life in terminally ill patients
McGill University Health Centre (MUHC) researcher Dr. Antonio Vigano has published a new study looking at the relationship between survival and quality of life in patients with terminal cancer.
MUHC researchers study the national impact of osteoporosis
Even a minor accident or fall could result in a potentially disabling fracture for as many as 60 percent of Canadian women over age 50.
Montreal Researchers Participate in HIV Vaccine Trial
Clinicians from the McGill University Health Centre and the Centre hospitalier de l'Université de Montréal (CHUM) are participating in the first Canadian therapeutic HIV vaccine trial.
New MS Research Shows Remarkable Findings
New research findings from the Research Institute of the McGill University Health Center (MUHC) provide hope for patients with multiple sclerosis (MS), one of the most common and devastating diseases of the nervous system.
Leprosy Susceptibility Genes Identified
The eradication of leprosy, one of the world's oldest and most feared diseases, may be one step closer.
